Pulse Biosciences completes 100-patient PRECISE-BTN enrollment; first patient reaches 12-month follow-up
Pulse Biosciences completed enrollment of 100 patients in the PRECISE-BTN study and the first patient finished the 12-month follow-up.Key Highlights:Original SEC Filing: PULSE BIOSCIENCES, INC. [ PLSE ] - 8-K - Sep. 15, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verify…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.